NUZ 0.00% 19.0¢ neurizon therapeutics limited

Ann: PharmAust to present at NWR Virtual Healthcare Conference, page-126

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. DB3
    43 Posts.
    lightbulb Created with Sketch. 20
    Sorry to keep floating ideas that may not be relevant but has anyone seen a study regarding MPL and its effects on the immune system. Specifically Regulatory T cells? There’s a lot of new research being done on T Reg cells and ALS. Specifically Coya Therapeutics with Dr. Stanley Appel. I can’t help but wonder if there’s a combination affect with monepantel or even if there’s a potential for a synergistic effect with both. Both are very exciting and appear to be entering a phase 2/3 this midyear.
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
0.000(0.00%)
Mkt cap ! $93.42M
Open High Low Value Volume
19.0¢ 19.3¢ 19.0¢ $25.41K 133.7K

Buyers (Bids)

No. Vol. Price($)
1 5372 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 262575 3
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.